CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ATAC project focuses on developing passive immunotherapy for COVID-19 by utilizing human antibodies derived from recovered patients. It employs various methods to characterize and optimize these antibodies, aiming to provide effective therapeutic candidates while ensuring compliance with regulatory standards.
ATAC aims at developing passive immunotherapy against COVID-19.
Human antibodies will be obtained from blood of CoV-recovered donors from China and Italy with three independent approaches: polyclonal gamma-globulins, B cell monoclonals and phage libraries.
Antibodies will be characterized by rapid experimental and computational work, optimized, produced and tested in consultation with EMA to ensure prompt embedding of regulatory aspects.
The partners have outstanding experience in all aspects of…
KAROLINSKA INSTITUTET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
TECHNISCHE UNIVERSITAET BRAUNSCHWEIG
Germany, Braunschweig
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
